Neurocrine Bioscience buy Morgan Stanley
Start price
04.02.25
/
50%
€148.00
Target price
04.02.26
€178.90
Performance (%)
-19.22%
Price
08:01
€119.55
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -19.22%. This prediction currently runs until 04.02.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.185% | -2.185% |
| iShares Core DAX® | -0.581% | -2.940% |
| iShares Nasdaq 100 | 0.824% | 3.718% |
| iShares Nikkei 225® | -0.630% | 5.126% |
| iShares S&P 500 | 0.643% | 2.253% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $170.00 to $185.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€121.85
05.09.25
05.09.25
€139.74
05.09.26
05.09.26
-1.89%
08:01
08:01
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€138.22
31.07.26
31.07.26
6.31%
08:01
08:01
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.50
22.07.25
22.07.25
€128.31
22.07.26
22.07.26
6.31%
08:01
08:01
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.00
07.03.25
07.03.25
€138.30
07.03.26
07.03.26
13.86%
08:01
08:01
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-17.17%
13.07.25
13.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25